Biomedicine & Pharmacotherapy

Dr. Duncan Ayers has completed his PhD in Translational Medicine from The University of Manchester (UK) in 2011 and is currently continuing his senior post-doctoral research at the University of Malta (CMMB). Dr. Ayers’ researchfocuses mainly on non-coding RNA biomarker discovery and therapeutic applications for paediatric cancers such as neuroblastoma. Other research interests include the influences of gene, micro RNA (miRNA) and other non-coding RNA expression profiles in the development of human disease conditions, high throughput semi-/quantitative gene (or miRNA, lncRNA, etc.) analytical techniques such as RT- qPCR, microarray platform utilization and the development of nanoparticle – based drug delivery systems for RNA interference -based therapeutics in cancer. Dr. Ayers’ research has been published / presented in over 40 reputed peer -reviewed journal papers and international meetings, together with contributing to five book publications.